OCULOCULAR THERAPEUTIX, INC
- Market cap
- $1.43B
- as of 2026-10-23
- Latest close
- $6.50
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-12-18
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Anderman ToddChief Legal Officer | Oct 8 | Oct 13 | S | 11,984 | $7.29 | Sale −$87,363 | 140,484 | Yes | Form 4 |
| Kaiser PeterChief Development Officer | Oct 2 | Oct 6 | S | 9,990 | $7.05 | Sale −$70,430 | 254,388 | Yes | Form 4 |
| Heier Jeffrey S.Chief Scientific Officer | Oct 2 | Oct 6 | S | 10,869 | $7.05 | Sale −$76,626 | 307,457 | Yes | Form 4 |
| Notman DonaldChief Operating Officer | Aug 31 | Sep 2 | S | 1,099 | $10.24 | Sale −$11,254 | 366,529 | No | Form 4 |
| Dugel PravinSee Remarks | Aug 25 | Aug 26 | G | 50,092 | $0.00 | $0 | not reported | Yes | Form 4 |
| Dugel PravinSee Remarks | Aug 25 | Aug 26 | G | 50,092 | $0.00 | $0 | 744,903 | Yes | Form 4 |
| Dugel PravinSee Remarks | Aug 24 | Aug 26 | S | 21,649 | $10.77 | Sale −$233,160 | 2,525,429 | Yes | Form 4 |
| Heier Jeffrey S.Chief Scientific Officer | Aug 24 | Aug 26 | S | 3,296 | $10.78 | Sale −$35,531 | 318,326 | Yes | Form 4 |
| Nayak SanjayChief Strategy Officer | Aug 24 | Aug 26 | S | 1,897 | $10.78 | Sale −$20,450 | 326,898 | Yes | Form 4 |
| Kaiser PeterChief Development Officer | Aug 24 | Aug 26 | S | 3,035 | $10.77 | Sale −$32,687 | 264,378 | Yes | Form 4 |
| Dugel PravinSee Remarks | Jun 16 | Jun 18 | G | 50,092 | $0.00 | $0 | 2,547,078 | No | Form 4 |
| Dugel PravinSee Remarks | Jun 16 | Jun 18 | G | 50,092 | $0.00 | $0 | 50,092 | No | Form 4 |
| Williams Leslie J. | Jun 10 | Jun 12 | A | 14,000 | $0.00 | $0 | 65,433 | No | Form 4 |
| Williams Leslie J. | Jun 10 | Jun 12 | A · derivative | 44,000 | $8.74 | $384,560 | 44,000 | No | Form 4 |
| Raines Merilee | Jun 10 | Jun 12 | A | 14,000 | $0.00 | $0 | 60,933 | No | Form 4 |
| Raines Merilee | Jun 10 | Jun 12 | A · derivative | 44,000 | $8.74 | $384,560 | 44,000 | No | Form 4 |
| Lindstrom Richard L Md | Jun 10 | Jun 12 | A | 14,000 | $0.00 | $0 | 260,933 | No | Form 4 |
| Lindstrom Richard L Md | Jun 10 | Jun 12 | A · derivative | 44,000 | $8.74 | $384,560 | 44,000 | No | Form 4 |
| Hong Seung Suh | Jun 10 | Jun 12 | A | 14,000 | $0.00 | $0 | 60,933 | No | Form 4 |
| Hong Seung Suh | Jun 10 | Jun 12 | A · derivative | 44,000 | $8.74 | $384,560 | 44,000 | No | Form 4 |
| Robins Jason ShandChief Financial Officer | Jun 10 | Jun 12 | A | 15,441 | $0.00 | $0 | 68,097 | No | Form 4 |
| Robins Jason ShandChief Financial Officer | Jun 10 | Jun 12 | A · derivative | 14,024 | $8.74 | $122,570 | 14,024 | No | Form 4 |
| Graves Adrienne L | Jun 10 | Jun 12 | A | 14,000 | $0.00 | $0 | 64,000 | No | Form 4 |
| Graves Adrienne L | Jun 10 | Jun 12 | A · derivative | 44,000 | $8.74 | $384,560 | 44,000 | No | Form 4 |
| Warden Charles M | Jun 10 | Jun 12 | A | 14,000 | $0.00 | $0 | 100,464 | No | Form 4 |
| Warden Charles M | Jun 10 | Jun 12 | A · derivative | 44,000 | $8.74 | $384,560 | 44,000 | No | Form 4 |
| Waheed NadiaChief Medical Officer | Jun 3 | Jun 5 | S | 14,828 | $8.27 | Sale −$122,628 | 300,079 | Yes | Form 4 |
| Dugel PravinSee Remarks | May 28 | May 28 | G | 394,696 | $0.00 | $0 | not reported | Yes | Form 4 |
| Dugel PravinSee Remarks | May 28 | May 28 | G | 394,696 | $0.00 | $0 | 694,811 | Yes | Form 4 |
| Nayak SanjayChief Strategy Officer | May 26 | May 28 | S | 1,858 | $8.20 | Sale −$15,236 | 328,795 | Yes | Form 4 |
| Heier Jeffrey S.Chief Scientific Officer | May 26 | May 28 | S | 3,018 | $8.20 | Sale −$24,748 | 320,350 | Yes | Form 4 |
| Kaiser PeterChief Development Officer | May 26 | May 28 | S | 2,967 | $8.20 | Sale −$24,329 | 266,141 | Yes | Form 4 |
| Dugel PravinSee Remarks | May 26 | May 28 | S | 21,156 | $8.20 | Sale −$173,479 | 2,597,170 | Yes | Form 4 |
| Dugel PravinSee Remarks | Apr 9 | Apr 13 | G | 394,696 | $0.00 | $0 | 2,618,326 | No | Form 4 |
| Dugel PravinSee Remarks | Apr 9 | Apr 13 | G | 394,696 | $0.00 | $0 | 394,696 | No | Form 4 |
| Nayak SanjayChief Strategy Officer | Feb 23 | Feb 25 | S | 1,759 | $8.28 | Sale −$14,565 | 330,653 | Yes | Form 4 |
| Heier Jeffrey S.Chief Scientific Officer | Feb 23 | Feb 25 | S | 3,057 | $8.28 | Sale −$25,312 | 323,368 | Yes | Form 4 |
| Kaiser PeterChief Development Officer | Feb 23 | Feb 25 | S | 2,810 | $8.28 | Sale −$23,267 | 269,108 | Yes | Form 4 |
| Dugel PravinSee Remarks | Feb 23 | Feb 25 | S | 20,056 | $8.28 | Sale −$166,064 | 3,013,022 | Yes | Form 4 |
| Lindstrom Richard L Md | Feb 20 | Feb 24 | P | 60,229 | $7.66 | Purchase +$461,354 | 246,933 | No | Form 4 |
| Waheed NadiaChief Medical Officer | Feb 20 | Feb 24 | S | 3,510 | $7.74 | Sale −$27,167 | 314,907 | Yes | Form 4 |
| Waheed NadiaChief Medical Officer | Feb 12 | Feb 17 | S | 7,863 | $9.04 | Sale −$71,082 | 318,417 | Yes | Form 4 |
| Dugel PravinSee Remarks | Feb 12 | Feb 17 | S | 124,882 | $9.04 | Sale −$1,128,933 | 3,033,078 | Yes | Form 4 |
| Nayak SanjayChief Strategy Officer | Feb 12 | Feb 17 | S | 10,348 | $9.04 | Sale −$93,546 | 332,412 | Yes | Form 4 |
| Notman DonaldChief Operating Officer | Feb 12 | Feb 17 | S | 11,446 | $9.04 | Sale −$103,472 | 366,356 | No | Form 4 |
| Notman DonaldChief Operating Officer | Feb 4 | Feb 4 | S | 6,035 | $8.54 | Sale −$51,539 | 377,802 | No | Form 4 |
| Notman DonaldChief Operating Officer | Feb 2 | Feb 4 | S | 5,455 | $9.14 | Sale −$49,859 | 383,837 | No | Form 4 |
| Robinson David WayneGlobal CCO | Jan 21 | Jan 26 | A | 136,000 | $0.00 | $0 | 136,000 | No | Form 4 |
| Robinson David WayneGlobal CCO | Jan 21 | Jan 26 | A · derivative | 416,000 | $11.42 | $4,750,720 | 416,000 | No | Form 4 |
| Robins Jason ShandInterim CFO | Jan 20 | Jan 22 | A · derivative | 33,000 | $11.45 | $377,850 | 33,000 | No | Form 4 |
| Notman DonaldSee Remarks | Jan 2 | Jan 6 | A | 79,112 | $0.00 | $0 | 389,292 | No | Form 4 |
| Notman DonaldSee Remarks | Jan 2 | Jan 6 | A · derivative | 240,932 | $11.82 | $2,847,816 | 240,932 | No | Form 4 |
| Heier Jeffrey S.Chief Scientific Officer | Jan 2 | Jan 6 | A | 79,112 | $0.00 | $0 | 326,425 | No | Form 4 |
| Heier Jeffrey S.Chief Scientific Officer | Jan 2 | Jan 6 | A · derivative | 240,932 | $11.82 | $2,847,816 | 240,932 | No | Form 4 |
| Waheed NadiaChief Medical Officer | Jan 2 | Jan 6 | A | 79,112 | $0.00 | $0 | 326,280 | No | Form 4 |
| Waheed NadiaChief Medical Officer | Jan 2 | Jan 6 | A · derivative | 240,932 | $11.82 | $2,847,816 | 240,932 | No | Form 4 |
| Saroj NamrataChief Business Officer | Jan 2 | Jan 6 | A | 79,112 | $0.00 | $0 | 254,620 | No | Form 4 |
| Saroj NamrataChief Business Officer | Jan 2 | Jan 6 | A · derivative | 240,932 | $11.82 | $2,847,816 | 240,932 | No | Form 4 |
| Kaiser PeterChief Development Officer | Jan 2 | Jan 6 | A | 79,112 | $0.00 | $0 | 271,918 | No | Form 4 |
| Kaiser PeterChief Development Officer | Jan 2 | Jan 6 | A · derivative | 240,932 | $11.82 | $2,847,816 | 240,932 | No | Form 4 |
| Nayak SanjayChief Strategy Officer | Jan 2 | Jan 6 | A | 64,900 | $0.00 | $0 | 342,760 | No | Form 4 |
| Nayak SanjayChief Strategy Officer | Jan 2 | Jan 6 | A · derivative | 197,650 | $11.82 | $2,336,223 | 197,650 | No | Form 4 |
| Meyers Steve LawrenceChief Commercial Officer | Jan 2 | Jan 6 | A | 64,900 | $0.00 | $0 | 217,628 | No | Form 4 |
| Meyers Steve LawrenceChief Commercial Officer | Jan 2 | Jan 6 | A · derivative | 197,650 | $11.82 | $2,336,223 | 197,650 | No | Form 4 |
| Anderman ToddChief Legal Officer | Jan 2 | Jan 6 | A | 64,900 | $0.00 | $0 | 152,468 | No | Form 4 |
| Anderman ToddChief Legal Officer | Jan 2 | Jan 6 | A · derivative | 197,650 | $11.82 | $2,336,223 | 197,650 | No | Form 4 |
| Dugel PravinSee Remarks | Nov 26, 2025 | Nov 26, 2025 | G | 49,754 | $0.00 | $0 | not reported | Yes | Form 4 |
| Dugel PravinSee Remarks | Nov 26, 2025 | Nov 26, 2025 | G | 49,754 | $0.00 | $0 | 300,115 | Yes | Form 4 |
| Heier Jeffrey S.Chief Scientific Officer | Nov 24, 2025 | Nov 26, 2025 | S | 3,469 | $12.04 | Sale −$41,767 | 245,940 | Yes | Form 4 |
| Kaiser PeterChief Development Officer | Nov 24, 2025 | Nov 26, 2025 | S | 3,007 | $12.02 | Sale −$36,144 | 191,433 | Yes | Form 4 |
| Dugel PravinSee Remarks | Nov 24, 2025 | Nov 26, 2025 | S | 19,530 | $12.04 | Sale −$235,141 | 3,157,960 | Yes | Form 4 |
| Nayak SanjayChief Strategy Officer | Nov 24, 2025 | Nov 26, 2025 | S | 1,878 | $12.04 | Sale −$22,611 | 277,860 | Yes | Form 4 |
| Saroj NamrataChief Business Officer | Nov 5, 2025 | Nov 7, 2025 | S | 25,865 | $10.74 | Sale −$277,790 | 174,135 | Yes | Form 4 |
| Anderman ToddChief Legal Officer | Oct 8, 2025 | Oct 10, 2025 | S | 11,132 | $12.34 | Sale −$137,369 | 87,568 | Yes | Form 4 |
| Heier Jeffrey S.Chief Scientific Officer | Oct 2, 2025 | Oct 6, 2025 | S | 10,502 | $11.04 | Sale −$115,942 | 249,409 | Yes | Form 4 |
| Kaiser PeterChief Development Officer | Oct 2, 2025 | Oct 6, 2025 | S | 9,653 | $11.03 | Sale −$106,473 | 194,440 | Yes | Form 4 |
| Dugel PravinSee Remarks | Sep 9, 2025 | Sep 11, 2025 | G | 49,754 | $0.00 | $0 | 3,177,490 | No | Form 4 |
| Dugel PravinSee Remarks | Sep 9, 2025 | Sep 11, 2025 | G | 49,754 | $0.00 | $0 | 49,754 | No | Form 4 |
| Notman DonaldSee Remarks | Sep 2, 2025 | Sep 4, 2025 | S | 1,066 | $12.43 | Sale −$13,250 | 308,807 | No | Form 4 |
| Dugel PravinSee Remarks | Aug 25, 2025 | Aug 27, 2025 | S | 21,494 | $12.04 | Sale −$258,788 | 3,227,244 | Yes | Form 4 |
| Heier Jeffrey S.Chief Scientific Officer | Aug 25, 2025 | Aug 27, 2025 | S | 3,063 | $12.04 | Sale −$36,879 | 259,911 | Yes | Form 4 |
| Nayak SanjayChief Strategy Officer | Aug 25, 2025 | Aug 27, 2025 | S | 1,885 | $12.04 | Sale −$22,695 | 279,738 | Yes | Form 4 |
| Kaiser PeterChief Development Officer | Aug 25, 2025 | Aug 27, 2025 | S | 3,011 | $12.04 | Sale −$36,252 | 204,093 | Yes | Form 4 |
| Waheed NadiaChief Medical Officer | Aug 12, 2025 | Aug 14, 2025 | A | 40,363 | $0.00 | $0 | 247,168 | No | Form 4 |
| Waheed NadiaChief Medical Officer | Aug 12, 2025 | Aug 14, 2025 | A · derivative | 122,923 | $12.48 | $1,534,079 | 122,923 | No | Form 4 |
| Dugel PravinSee Remarks | Aug 11, 2025 | Aug 13, 2025 | G | 250,361 | $0.00 | $0 | 250,361 | No | Form 4 |
| Dugel PravinSee Remarks | Jun 12, 2025 | Aug 13, 2025 | G | 50,029 | $0.00 | $0 | 3,248,738 | No | Form 4 |
| Dugel PravinSee Remarks | Apr 28, 2025 | Aug 13, 2025 | G | 200,332 | $0.00 | $0 | 3,298,767 | No | Form 4 |
| Graves Adrienne L | Jun 11, 2025 | Jun 13, 2025 | A | 14,000 | $0.00 | $0 | 50,000 | No | Form 4 |
| Graves Adrienne L | Jun 11, 2025 | Jun 13, 2025 | A · derivative | 44,000 | $8.82 | $388,080 | 44,000 | No | Form 4 |
| Warden Charles M | Jun 11, 2025 | Jun 13, 2025 | A | 14,000 | $0.00 | $0 | 86,464 | No | Form 4 |
| Warden Charles M | Jun 11, 2025 | Jun 13, 2025 | A · derivative | 44,000 | $8.82 | $388,080 | 44,000 | No | Form 4 |
| Williams Leslie J. | Jun 11, 2025 | Jun 13, 2025 | A | 14,000 | $0.00 | $0 | 51,433 | No | Form 4 |
| Williams Leslie J. | Jun 11, 2025 | Jun 13, 2025 | A · derivative | 44,000 | $8.82 | $388,080 | 44,000 | No | Form 4 |
| Lindstrom Richard L Md | Jun 11, 2025 | Jun 13, 2025 | A | 14,000 | $0.00 | $0 | 143,145 | No | Form 4 |
| Lindstrom Richard L Md | Jun 11, 2025 | Jun 13, 2025 | A · derivative | 44,000 | $8.82 | $388,080 | 44,000 | No | Form 4 |
| Raines Merilee | Jun 11, 2025 | Jun 13, 2025 | A | 14,000 | $0.00 | $0 | 46,933 | No | Form 4 |
| Raines Merilee | Jun 11, 2025 | Jun 13, 2025 | A · derivative | 44,000 | $8.82 | $388,080 | 44,000 | No | Form 4 |
| Hong Seung Suh | Jun 11, 2025 | Jun 13, 2025 | A | 14,000 | $0.00 | $0 | 46,933 | No | Form 4 |
| Hong Seung Suh | Jun 11, 2025 | Jun 13, 2025 | A · derivative | 44,000 | $8.82 | $388,080 | 44,000 | No | Form 4 |
| Dugel PravinSee Remarks | Jun 11, 2025 | Jun 13, 2025 | A · derivative | 2,750,000 | $7.44 | $20,460,000 | 2,750,000 | No | Form 4 |
| Waheed NadiaChief Medical Officer | Jun 2, 2025 | Jun 3, 2025 | S | 13,861 | $8.05 | Sale −$111,581 | 206,805 | Yes | Form 4 |
| Dugel PravinSee Remarks | May 23, 2025 | May 27, 2025 | S | 21,219 | $7.18 | Sale −$152,352 | 3,499,099 | Yes | Form 4 |
| Heier Jeffrey S.Chief Scientific Officer | May 23, 2025 | May 27, 2025 | S | 3,024 | $7.18 | Sale −$21,712 | 262,974 | Yes | Form 4 |
| Kaiser PeterChief Development Officer | May 23, 2025 | May 27, 2025 | S | 2,974 | $7.17 | Sale −$21,324 | 207,104 | Yes | Form 4 |
| Nayak SanjayChief Strategy Officer | May 23, 2025 | May 27, 2025 | S | 1,862 | $7.17 | Sale −$13,351 | 281,623 | Yes | Form 4 |
| Lindstrom Richard L Md | May 8, 2025 | May 12, 2025 | P | 10,000 | $6.96 | Purchase +$69,600 | 172,704 | No | Form 4 |
| Nayak SanjayChief Strategy Officer | Feb 24, 2025 | Feb 26, 2025 | S | 1,895 | $6.84 | Sale −$12,962 | 283,485 | Yes | Form 4 |
| Kaiser PeterChief Development Officer | Feb 24, 2025 | Feb 26, 2025 | S | 3,009 | $6.87 | Sale −$20,672 | 210,078 | Yes | Form 4 |
| Heier Jeffrey S.Chief Scientific Officer | Feb 24, 2025 | Feb 26, 2025 | S | 3,061 | $6.87 | Sale −$21,029 | 265,998 | Yes | Form 4 |
| Dugel PravinSee Remarks | Feb 24, 2025 | Feb 26, 2025 | S | 21,475 | $6.87 | Sale −$147,533 | 3,520,318 | Yes | Form 4 |
| Nayak SanjayChief Strategy Officer | Feb 11, 2025 | Feb 13, 2025 | A | 111,000 | $0.00 | $0 | 285,380 | No | Form 4 |
| Nayak SanjayChief Strategy Officer | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 334,000 | $7.44 | $2,484,960 | 334,000 | No | Form 4 |
| Notman DonaldSee Remarks | Feb 11, 2025 | Feb 13, 2025 | A | 115,000 | $0.00 | $0 | 308,444 | No | Form 4 |
| Notman DonaldSee Remarks | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 344,115 | $7.44 | $2,560,216 | 344,115 | No | Form 4 |
| Waheed NadiaChief Medical Officer | Feb 11, 2025 | Feb 13, 2025 | A | 79,000 | $0.00 | $0 | 220,666 | No | Form 4 |
| Waheed NadiaChief Medical Officer | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 237,000 | $7.44 | $1,763,280 | 237,000 | No | Form 4 |
| Dugel PravinSee Remarks | Feb 11, 2025 | Feb 13, 2025 | A | 1,250,000 | $0.00 | $0 | 2,041,793 | No | Form 4 |
| Dugel PravinSee Remarks | Feb 11, 2025 | Feb 13, 2025 | A | 1,500,000 | $0.00 | $0 | 3,541,793 | No | Form 4 |
| Notman DonaldSee Remarks | Feb 4, 2025 | Feb 4, 2025 | S | 11,119 | $7.81 | Sale −$86,839 | 193,444 | No | Form 4 |
| Notman DonaldSee Remarks | Jan 31, 2025 | Feb 4, 2025 | S | 6,301 | $7.84 | Sale −$49,400 | 204,563 | No | Form 4 |
| Dugel PravinSee Remarks | Nov 25, 2024 | Nov 27, 2024 | S | 20,680 | $9.01 | Sale −$186,327 | 791,793 | Yes | Form 4 |
| Nayak SanjayChief Strategy Officer | Nov 25, 2024 | Nov 27, 2024 | S | 1,814 | $9.00 | Sale −$16,326 | 174,380 | Yes | Form 4 |
| Kaiser PeterChief Development Officer | Nov 25, 2024 | Nov 27, 2024 | S | 2,897 | $9.01 | Sale −$26,102 | 213,087 | Yes | Form 4 |
| Heier Jeffrey S.Chief Scientific Officer | Nov 25, 2024 | Nov 27, 2024 | S | 2,948 | $9.01 | Sale −$26,561 | 269,059 | Yes | Form 4 |
| Anderman ToddChief Legal Officer | Oct 7, 2024 | Oct 9, 2024 | A | 98,700 | $0.00 | $0 | 98,700 | No | Form 4 |
| Anderman ToddChief Legal Officer | Oct 7, 2024 | Oct 9, 2024 | A · derivative | 296,500 | $9.48 | $2,810,820 | 296,500 | No | Form 4 |
| Heier Jeffrey S.Chief Scientific Officer | Oct 2, 2024 | Oct 4, 2024 | A | 100,000 | $0.00 | $0 | 272,007 | No | Form 4 |
| Heier Jeffrey S.Chief Scientific Officer | Oct 2, 2024 | Oct 4, 2024 | A · derivative | 200,000 | $9.31 | $1,862,000 | 200,000 | No | Form 4 |
| Kaiser PeterChief Development Officer | Oct 2, 2024 | Oct 4, 2024 | A | 100,000 | $0.00 | $0 | 215,984 | No | Form 4 |
| Kaiser PeterChief Development Officer | Oct 2, 2024 | Oct 4, 2024 | A · derivative | 200,000 | $9.31 | $1,862,000 | 200,000 | No | Form 4 |
| Notman DonaldSee Remarks | Aug 29, 2024 | Sep 3, 2024 | A | 11,034 | $0.00 | $0 | 208,988 | No | Form 4 |
| Notman DonaldSee Remarks | Aug 29, 2024 | Sep 3, 2024 | A · derivative | 33,602 | $8.56 | $287,633 | 33,602 | No | Form 4 |
| Dugel PravinSee Remarks | Aug 23, 2024 | Aug 27, 2024 | S | 20,880 | $9.02 | Sale −$188,338 | 812,473 | Yes | Form 4 |
| Nayak SanjayChief Strategy Officer | Aug 23, 2024 | Aug 27, 2024 | S | 1,832 | $9.02 | Sale −$16,525 | 176,194 | Yes | Form 4 |
| Graves Adrienne L | Jul 24, 2024 | Jul 26, 2024 | A | 12,000 | $0.00 | $0 | 36,000 | No | Form 4 |
| Graves Adrienne L | Jul 24, 2024 | Jul 26, 2024 | A · derivative | 36,000 | $7.91 | $284,760 | 36,000 | No | Form 4 |
| Warden Charles M | Jul 24, 2024 | Jul 26, 2024 | A | 12,000 | $0.00 | $0 | 72,464 | No | Form 4 |
| Warden Charles M | Jul 24, 2024 | Jul 26, 2024 | A · derivative | 36,000 | $7.91 | $284,760 | 36,000 | No | Form 4 |
| Williams Leslie J. | Jul 24, 2024 | Jul 26, 2024 | A | 12,000 | $0.00 | $0 | 37,433 | No | Form 4 |
| Williams Leslie J. | Jul 24, 2024 | Jul 26, 2024 | A · derivative | 36,000 | $7.91 | $284,760 | 36,000 | No | Form 4 |
| Raines Merilee | Jul 24, 2024 | Jul 26, 2024 | A | 12,000 | $0.00 | $0 | 32,933 | No | Form 4 |
| Raines Merilee | Jul 24, 2024 | Jul 26, 2024 | A · derivative | 36,000 | $7.91 | $284,760 | 36,000 | No | Form 4 |
| Hong Seung Suh | Jul 24, 2024 | Jul 26, 2024 | A | 12,000 | $0.00 | $0 | 32,933 | No | Form 4 |
| Hong Seung Suh | Jul 24, 2024 | Jul 26, 2024 | A · derivative | 36,000 | $7.91 | $284,760 | 36,000 | No | Form 4 |
| Lindstrom Richard L Md | Jul 24, 2024 | Jul 26, 2024 | A | 12,000 | $0.00 | $0 | 162,704 | No | Form 4 |
| Lindstrom Richard L Md | Jul 24, 2024 | Jul 26, 2024 | A · derivative | 36,000 | $7.91 | $284,760 | 36,000 | No | Form 4 |
| Lindstrom Richard L Md | Feb 27, 2024 | Jul 26, 2024 | M | 18,939 | $8.80 | $166,663 | 139,341 | No | Form 4 |
| Lindstrom Richard L Md | Feb 27, 2024 | Jul 26, 2024 | M | 11,363 | $8.80 | $99,994 | 150,704 | No | Form 4 |
| Lindstrom Richard L Md | Feb 27, 2024 | Jul 26, 2024 | M · derivative | 18,939 | $8.80 | $166,663 | not reported | No | Form 4 |
| Lindstrom Richard L Md | Feb 27, 2024 | Jul 26, 2024 | M · derivative | 11,363 | $8.80 | $99,994 | not reported | No | Form 4 |
| Waheed NadiaChief Medical Officer | Jun 1, 2024 | Jun 4, 2024 | A | 141,666 | $0.00 | $0 | 141,666 | No | Form 4 |
| Waheed NadiaChief Medical Officer | Jun 1, 2024 | Jun 4, 2024 | A · derivative | 425,000 | $5.70 | $2,422,500 | 425,000 | No | Form 4 |
| Dugel PravinSee Remarks | May 23, 2024 | May 28, 2024 | S | 21,626 | $5.79 | Sale −$125,215 | 833,353 | Yes | Form 4 |
| Nayak SanjayChief Strategy Officer | May 23, 2024 | May 28, 2024 | S | 2,274 | $5.84 | Sale −$13,280 | 178,026 | Yes | Form 4 |
| Summer Road LLC | Feb 26, 2024 | Feb 27, 2024 | P | 930,851 | $7.52 | Purchase +$7,000,000 | 8,591,401 | No | Form 4 |
| Nayak SanjayChief Strategy Officer | Feb 22, 2024 | Feb 26, 2024 | A | 80,300 | $0.00 | $0 | 180,300 | No | Form 4 |
| Nayak SanjayChief Strategy Officer | Feb 22, 2024 | Feb 26, 2024 | A · derivative | 244,550 | $9.70 | $2,372,135 | 244,550 | No | Form 4 |
| Dugel PravinExecutive Chairman | Feb 22, 2024 | Feb 26, 2024 | A | 854,979 | $0.00 | $0 | 854,979 | No | Form 4 |
| Dugel PravinExecutive Chairman | Feb 22, 2024 | Feb 26, 2024 | A · derivative | 1,282,469 | $9.70 | $12,439,949 | 1,282,469 | No | Form 4 |
| Mattessich Antony C.President and CEO | Feb 5, 2024 | Feb 6, 2024 | S | 19,642 | $4.86 | Sale −$95,460 | 588,701 | No | Form 4 |
| Notman DonaldChief Financial Officer | Feb 5, 2024 | Feb 6, 2024 | S | 6,212 | $4.86 | Sale −$30,190 | 195,356 | No | Form 4 |
| Ozden Rabia GursesChief Medical Officer | Feb 5, 2024 | Feb 6, 2024 | S | 6,346 | $4.86 | Sale −$30,842 | 153,054 | No | Form 4 |
| Strassburger Philip C.General Counsel | Feb 5, 2024 | Feb 6, 2024 | S | 6,029 | $4.86 | Sale −$29,301 | 161,493 | No | Form 4 |
| White Christopher GChief Business Officer | Feb 5, 2024 | Feb 6, 2024 | S | 5,910 | $4.86 | Sale −$28,723 | 123,689 | No | Form 4 |
| Mattessich Antony C.President and CEO | Feb 3, 2024 | Feb 6, 2024 | A | 180,400 | $0.00 | $0 | 608,343 | No | Form 4 |
| Mattessich Antony C.President and CEO | Feb 3, 2024 | Feb 6, 2024 | A · derivative | 549,400 | $5.18 | $2,845,892 | 549,400 | No | Form 4 |
| Notman DonaldChief Financial Officer | Feb 3, 2024 | Feb 6, 2024 | A | 61,636 | $0.00 | $0 | 201,568 | No | Form 4 |
| Notman DonaldChief Financial Officer | Feb 3, 2024 | Feb 6, 2024 | A · derivative | 185,000 | $5.18 | $958,300 | 185,000 | No | Form 4 |
| Ozden Rabia GursesChief Medical Officer | Feb 3, 2024 | Feb 6, 2024 | A | 66,633 | $0.00 | $0 | 159,400 | No | Form 4 |
| Ozden Rabia GursesChief Medical Officer | Feb 3, 2024 | Feb 6, 2024 | A · derivative | 200,000 | $5.18 | $1,036,000 | 200,000 | No | Form 4 |
| Strassburger Philip C.General Counsel | Feb 3, 2024 | Feb 6, 2024 | A | 58,304 | $0.00 | $0 | 167,522 | No | Form 4 |
| Strassburger Philip C.General Counsel | Feb 3, 2024 | Feb 6, 2024 | A · derivative | 175,000 | $5.18 | $906,500 | 175,000 | No | Form 4 |
| White Christopher GChief Business Officer | Feb 3, 2024 | Feb 6, 2024 | A | 39,980 | $0.00 | $0 | 129,599 | No | Form 4 |
| White Christopher GChief Business Officer | Feb 3, 2024 | Feb 6, 2024 | A · derivative | 120,000 | $5.18 | $621,600 | 120,000 | No | Form 4 |
| Mattessich Antony C.President and CEO | Jan 31, 2024 | Feb 2, 2024 | S | 18,338 | $4.95 | Sale −$90,773 | 427,943 | No | Form 4 |
| White Christopher GChief Business Officer | Jan 31, 2024 | Feb 2, 2024 | S | 5,147 | $4.95 | Sale −$25,478 | 89,619 | No | Form 4 |
| Strassburger Philip C.General Counsel | Jan 31, 2024 | Feb 2, 2024 | S | 6,831 | $4.95 | Sale −$33,813 | 109,218 | No | Form 4 |
| Ozden Rabia GursesChief Medical Officer | Jan 31, 2024 | Feb 2, 2024 | S | 7,764 | $4.95 | Sale −$38,432 | 92,767 | No | Form 4 |
| Notman DonaldChief Financial Officer | Jan 31, 2024 | Feb 2, 2024 | S | 6,433 | $4.95 | Sale −$31,843 | 139,932 | No | Form 4 |
| Summer Road LLC | Dec 14, 2023 | Dec 18, 2023 | P | 1,538,461 | $3.25 | Purchase +$4,999,998 | 7,660,550 | No | Form 4 |